Concert Pharmaceuticals

Concert Pharmaceuticals

Verified
Concert Home Page - Concert Pharmaceuticals

Launch date
Employees
Ownership
Market cap
$212m
Net debt
$42.5m
Firm valuation
$232m (Public information from Aug 2022)
Lexington Kentucky (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-131m9.1m<1m6.4m29.1m-
% growth--(93 %)(90 %)600 %357 %-
EBITDA-84.5m(49.1m)-(64.5m)(64.5m)(111m)
% EBITDA margin-65 %(540 %)-(1014 %)(222 %)-
Profit-86.4m(50.9m)(70.9m)(67.3m)(66.4m)(115m)
% profit margin-66 %(560 %)(7800 %)(1057 %)(228 %)-
EV / revenue-2.7x26.3x100.0x32.3x-119.0x
EV / EBITDA-4.1x-5.1x--3.6x0.6x-0.4x
R&D budget35m25m-52m---
R&D % of revenue-19 %-5720 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/A$10mSeries A
Not yet verified
$48.5mSeries B
Not yet verified
N/A$37mSeries C
Not yet verified
$4mEarly VC
Not yet verified
N/AN/AIPO
$30mPost IPO Debt
Not yet verified
N/A$74.7mPost IPO Equity
Not yet verified
$65mPost IPO Equity
Total Funding-

Recent News about Concert Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.